| Market Cap | ₹17,301Cr |
| ROE | 12.09% |
| P/E Ratio(TTM) | 96.58 |
| EPS(TTM) | 139.62 |
| P/B Ratio | 10.68 |
| Dividend Yield | 0.09% |
| Industry P/E | 32.40 |
| Book Value | 1262.09 |
| Debt to Equity | 0.16 |
| Face Value | 10 |
| Managing Director | Mr. Davuluri Sucheth Rao |
| Founded | 1984 |
| NSE Symbol | NEULANDLAB |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 65.94 | ||
| Acutaas Chemicals | NA (0.00%) | 57.50 | ||
| Jubilant Pharmova | NA (0.00%) | 34.72 | ||
| Gujarat Themis Biosyn | NA (0.00%) | 77.24 |